Scienmag

NOVEMBER 13, 2020

Smidt Heart Institute Chair of Cardiology presents new findings at American Heart Association Scientific Sessions Credit: Photo by Cedars-Sinai LOS ANGELES (Nov.

Cardiology 85

Cardiology Development Research Medicine 85

Medical Xpress

APRIL 27, 2023

A research team from Wake Forest University School of Medicine has developed an open-source, web-based application that allows users to generate customized hypertension statistics using National Health and Nutrition Examination Survey (NHANES) data.

Development 71

Development Research Medicine Cardiology 71

Rethinking Clinical Trials

APRIL 13, 2023

Nudges and other behavioral interventions are prevalent in industries like business and entertainment, but there is an opportunity for nudges in medicine and health care delivery. Launched in 2016, the Penn Medicine Nudge Unit is the world’s first behavioral design team embedded within a health system.

Medicine 100

Medicine Trials Cardiology Development 100

Medical Xpress

DECEMBER 7, 2022

Mann Department of Biomedical Engineering have developed a "heart attack on a chip," a device that could one day serve as a testbed to develop new heart drugs and even personalized medicines. Researchers at the University of Southern California Alfred E.

Engineer 104

Engineer Medicine Development Drugs 104

Rethinking Clinical Trials

JULY 19, 2023

Distinguished Professor of Medicine Professor of Nursing Duke University Neha J. This was a cluster-randomized trial of 42 cardiology clinics across the U.S., The cardiology clinics were randomized to one of two groups.     Speaker Christopher B. Granger, MD Donald F. Fortin, M.D.

Trials 100

Trials Cardiology Medicine Nurses 100

The Pharma Data

DECEMBER 12, 2020

We look forward to welcoming our new colleagues at Alexion so that we can together build on our combined expertise in immunology and precision medicines to drive innovation that delivers life-changing medicines for more patients.” ” Ludwig Hantson , Ph.D., Strategic rationale.

Development 75

Development Regulation Medicine Containment 75

Scienmag

NOVEMBER 19, 2020

Department of Molecular Pharmacology, Shinshu University School of Medicine, Japan Researchers have identified a new druggable target for heart failure in neonates and infants, a condition for which there has been no specific treatment. Credit: Mitsuhiko Yamada MD, PhD.,

Medicine 97

Medicine Drugs Development Research 97

Medical Xpress

MAY 11, 2023

An algorithm developed using artificial intelligence could soon be used by doctors to diagnose heart attacks with better speed and accuracy than ever before, according to new research from the University of Edinburgh published in Nature Medicine.

Doctor 93

Doctor Doctors Medicine Development 93

Scienmag

MARCH 11, 2021

Credit: Dr Maik Pietzner at the MRC Epidemiology Unit A new study published today in Nature Medicine has identified key risk factors that increase the likelihood of individuals developing not only one but multiple non-communicable diseases, which include cardiovascular disease, cancer, chronic respiratory disease and diabetes.

Medicine 93

Medicine Development Cardiology 93

BioPharma Reporter

MAY 23, 2023

Neurimmune has announced that primary results of its phase 1 proof-of-concept study of NI006, a recombinant human antibody to deplete amyloid deposits in ATTR cardiomyopathy, have been presented in Prague at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC), and published in The New England Journal of Medicine.

Cardiology 52

Cardiology Antibody Medicine Development 52

Scienmag

OCTOBER 18, 2020

Beijing, China 19 Oct 2020: Elevated birth weight is linked with developing atrial fibrillation later in life, according to research presented at the 31st Great Wall International Congress of Cardiology (GW-ICC). Faculty from the European Society of Cardiology (ESC) will participate in joint scientific […].

Cardiology 43

Cardiology Development Research Medicine 43

Scienmag

JULY 22, 2021

New USDA-NIFA funding brings together research, academics, and Extension to improve knowledge, access, and self-monitoring skills for hypertension management Credit: Edwin Remsberg, University of Maryland To address the significant health burden of hypertension (characterized by consistently high blood pressure), the University of Maryland (UMD) was (..)

Development 93

Development Research Cardiology Medicine 93

Scienmag

MARCH 8, 2021

Identifies people at high risk of heart attack despite average LDL cholesterol levels Rome, Italy, March 8, 2021 – Allelica, a leading genomics software company specialising in developing polygenic risk scores (PRS) for personalised medicine, today announced publication of a study in Circulation (Vol.

Genome 75

Genome Genomics Medicine Development 75

Scienmag

JULY 16, 2021

A scientific review has found evidence that a disruption in blood clotting and the first line immune system could be contributing factors in the development of psychosis.

Medicine 73

Medicine Development Research Allergies 73

Medical Xpress

APRIL 17, 2023

A KAIST research team led by Professor Keon Jae Lee from the Department of Materials Science and Engineering and the College of Medicine of the Catholic University of Korea has developed a highly sensitive, wearable piezoelectric blood pressure sensor.

Engineer 72

Engineer Medicine Development Research 72

Scienmag

APRIL 20, 2021

Researchers at Penn Medicine uncover more genetic mutations that predispose women to peripartum cardiomyopathy, with implications for the future of increased genetic testing PHILADELPHIA– Researchers at Penn Medicine have identified more genetic mutations that strongly predispose younger, otherwise healthy women to peripartum cardiomyopathy (PPCM), (..)

Genetics 45

Genetics Development Medicine Research 45

XTalks

JULY 19, 2021

Phosphorus, a leading preventative genomics company, has developed the first comprehensive preventative genetic test for consumers. Phosphorus may be a familiar name as it was one of the first to develop an FDA-authorized at-home test for COVID-19 ; it was also the first test to have received an asymptomatic, direct-to-consumer FDA approval.

Genetics 98

Genetics Genome Genomics Gene 98

Scienmag

JUNE 27, 2021

Sophia Antipolis – 28 June 2021: A study in more than 200,000 individuals has found that patients with heart failure are more likely to develop cancer compared to their peers without heart failure.

Cardiology 40

Cardiology Development Research Medicine 40

Scienmag

JUNE 17, 2021

Tools for clinicians in point-of-care use UTICA, NY — More than 2 million coronary artery stents are implanted each year to help protect or restore normal blood flow to the heart, to treat patients suffering from angina or a heart attack due to coronary artery disease (CAD). While stents are highly effective and safe devices, […].

Research 72

Research Development Clinical Trials Clinical Trials 72

pharmaphorum

JUNE 1, 2021

Novo Nordisk is paying $55 million upfront to secure rights to a cell therapy for heart failure developed by Japanese startup Heartseed. Working out which are more likely to benefit from stem cell therapy is likely to be a key challenge for developers. An interim look at the results is due later this month.

Trials 138

Trials Development Licensing Licensing 138

The Pharma Data

JUNE 28, 2021

The approval is based on the results of the pivotal Phase III VICTORIA trial, published in The New England Journal of Medicine (NEJM) in March 2020. Vericiguat is being jointly developed with MSD (a tradename of Merck & Co., The vericiguat program is being co-developed by Bayer and MSD. Verquvo (vericiguat) 2.5

Cardiology 52

Cardiology Production Development Medicine 52

Scienmag

NOVEMBER 13, 2020

Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.

Clinical Trials 61

Clinical Trials Clinical Trials Drugs Medicine 61

pharmaphorum

OCTOBER 2, 2020

He has used innovative and collaborative strategies to develop and refine a multi-modality ‘recruitment engine’ and led one of the UK’s first ‘virtual’ interventional trials. His main interest is in improving access to clinical trials through community-based participation, consent for contact registries and a digital media platform.

Clinical Trials 92

Clinical Trials Clinical Trials Clinical Research Life Science 92

Scienmag

MAY 1, 2021

Boston, MA (May 1, 2021) – A new study presented today at the AATS 101st Annual Meeting, found that the percentage of patients undergoing esophagectomy for cancer who suffer Venous Thromboembolism (VTE) post-operatively is much higher than previously reported, with as many as 24 percent suffering from Deep Vein Thrombosis (DVT) or Pulmonary Embolism (..)

Development 67

Development Cardiology Medicine 67

The Pharma Data

MARCH 22, 2022

.–(BUSINESS WIRE)– Bristol Myers Squibb (NYSE: BMY) today announced that data from its cardiovascular portfolio will be presented at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22), senior vice president, head of cardiovascular development and global drug development at Bristol Myers Squibb. “We

Clinical Trials 52

Clinical Trials Clinical Trials Cardiology Trials 52

FDA Law Blog

FEBRUARY 21, 2022

Unger, who is a 1971 recipient of the Rensselaer Polytechnic Institute Mathematics and Science Medal, earned a Bachelor of Science (magna cum laude) in chemistry from Wright State University in Dayton, Ohio, and a Doctor of Medicine from the University of Cincinnati College of Medicine in Cincinnati, Ohio.

Drugs 40

Drugs Cardiology FDA Approval Doctors 40

Scienmag

MARCH 19, 2021

Scientists at The Ohio State University Wexner Medical Center, College of Engineering and College of Medicine have developed technology to “retrain” cells to help repair damaged brain tissue.

Scientist 57

Scientist Engineer Medicine Development 57

Scienmag

OCTOBER 8, 2020

ACC leaders will also present on management of acute coronary syndrome during conference The American College of Cardiology’s (ACC) Hani Najm Global Scholar Awards program was announced at the opening session of the Saudi Heart Association Annual Conference on Oct.

Cardiology 40

Cardiology Development Medicine 40

The Pharma Data

FEBRUARY 21, 2022

At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business growth by bringing forward new options for patients. “We

Radiology 52

Radiology Cardiology Development Production 52

Scienmag

DECEMBER 3, 2020

Credit: Journal of Internal Medicine A new study suggests that COVID-19 guidance in Sweden may have reduced people’s risks of having a heart attack.

Medicine 52

Medicine Development Research Cardiology 52

Velocity Clinical Research

DECEMBER 6, 2023

In addition to being one of Poland’s top recruiting sites in cardiology trials, ClinMedica also recruits patients across a broad range of therapeutic areas involving ambulatory medicine. About Grzegorz Kania, MD Grzegorz Kania, MD specializes in cardiology as well as internal and family medicine. and Europe.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Scienmag

JUNE 18, 2021

Credit: University of California San Diego A hydrogel that forms a barrier to keep heart tissue from adhering to surrounding tissue after surgery was developed and successfully tested in rodents by a team of University of California San Diego researchers.

Engineer 98

Engineer Scientist Development Research 98

The Pharma Data

OCTOBER 14, 2020

. “I was so frustrated forcing these yucky and sticky syrup medicines into my son when he was sick. Now, we have a large pipeline of gummy drugs in development, from allergy and pain relief medications to fever reducers and cough suppressants. We are here to solve these problems.”

Drugs 40

Drugs Allergies Cardiology Medicine 40

Scienmag

DECEMBER 2, 2020

Mutations in CHD7 cause severe birth defects known as CHARGE syndrome cases, which include severe and life-threatening heart malformations. Credit: UAB BIRMINGHAM, Ala. – Research by Kai Jiao, M.D.,

Protein 52

Protein Development Research Cardiology 52

Scienmag

APRIL 27, 2021

Researchers from Belgium, the Netherlands, Russia, and Italy have developed a breakthrough method for quickly, accurately, and reliably diagnosing cardiac arrhythmias. This is a unique method to diagnose pathogenic areas in the heart in a minute Credit: Front. They called it Directed graph mapping (DGM).

Scientist 96

Scientist Development Research Clinical Trials 96

The Pharma Data

NOVEMBER 4, 2020

. “Telehealth is great, but it may actually exaggerate these disparities even further that we see in care right now,” said study author Dr. Salim Virani, a professor of medicine and cardiology at Baylor College of Medicine in Houston.

Doctors 52

Doctors Doctor Medicine Cardiology 52

ACRP blog

JANUARY 24, 2023

Raising Community Awareness to Optimize Impact Nevada’s first integrated health system was created in June 2021 when an affiliation agreement was signed between Renown Health and the University of Nevada, Reno, School of Medicine. Significant progress was achieved.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52